Open an account

Trupanion

TRUP · NASDAQ

$28.76+$1.26 (+4.58%)TodayMarket closed ·
Prev close $27.50

About TRUP

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. The company is headquartered in Seattle, Washington and currently employs 1,121 full-time employees. The company went IPO on 2014-07-18. The firm operates in two segments, namely, Subscription Business and Other Business. The Subscription Business segment includes subscription fees related to the Company's direct-to-consumer products. The Other Business segment comprises other product offerings that generally have a business-to-business relationship and a different margin profile than its subscription segment, including writing policies on behalf of third parties and other products and software solutions. The company offers Trupanion, software that is designed to communicate directly with veterinary hospital's practice management software. The company provides Powered by Trupanion pet insurance product offerings marketed by third parties and marketed under the brand names Furkin and PHI Direct in Canada, and a Trupanion branded product in Germany and Switzerland.

Employees
1,121
Headquarters
Seattle, Washington
Listed
Jul 18, 2014
Sector
Financials
Industry
Insurance
Website
trupanion.com

TRUP key statistics

Market cap
1.26B
Price-earnings ratio
51.89
Dividend yield
—
Average volume
422.29K
Volume
234.21K
Open price
$27.57
High today
$28.81
Low today
$27.55
52 Week high
$46.98
52 Week low
$21.16

Trupanion (TRUP) at a glance

Trupanion (TRUP) last traded at $28.76, with a market cap of 1.26B and a price-to-earnings ratio of 51.89.

Today the stock has traded between $27.55 and $28.81. The current price is 4.4% above the day's low and 0.2% below its high.

Volume so far is 234.21K shares, below the average of 422.29K shares a day.

Over the past year Trupanion has ranged from $21.16 to $46.98, and now sits 29% of the way up that range.

Trupanion met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.16 per share against an estimate of $0.1156.

The average analyst price target is $34.94, 21.5% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

40%of 5 analyst ratings say Buy
  • Buy40.0%
  • Hold60.0%
  • Sell0.0%
Price target · 6 analystsAvg $34.94
Low
$29.29
Now
$28.76
High
$44.10

TRUP earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 105.9% on average.

  1. Q3 FY24: reported $0.03 per share against an estimate of -$0.0625
  2. Q4 FY24: reported $0.16 per share against an estimate of $0.0758
  3. Q1 FY25: reported -$0.03 per share against an estimate of -$0.0493
  4. Q2 FY25: reported $0.06 per share against an estimate of -$0.0265
  5. Q3 FY25: reported $0.13 per share against an estimate of $0.102
  6. Q4 FY25: reported $0.13 per share against an estimate of $0.1649
  7. Q1 FY26: reported $0.11 per share against an estimate of $0.0731
  8. Q2 FY26: reported $0.16 per share against an estimate of $0.1156

TRUP news

  • Press releasePRNewswire

    HABRI and Trupanion Announce Strategic Partnership

  • Assessing Trupanion: Insights From 4 Financial Analysts

  • Press releasePRNewswire

    25 Years of Paws and Protection: Trupanion Reflects on a Quarter-Century of Protecting Our Furry Best Friends

  • Press releaseGlobe Newswire

    Trupanion Named One of Seattle's Best Places to Work for the 7th Year in a Row

  • Namrata Sen

    From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

  • Press releasePRNewswire

    Trupanion's Commitment to Mission Highlighted as CEO Named 'Woman of Influence' by Puget Sound Business Journal

  • Avi Kapoor

    Top 3 Financial Stocks That May Explode In Q4

  • Earnings Scheduled For November 6, 2025

Similar companies

Companies in the same industry as Trupanion

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.